Related Experiment Video
Updated: Dec 14, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Association of HMIP1 C-893A polymorphism and disease severity in patients with sickle cell anemia
Diego A Pereira-Martins1, Igor F Domingos2, Edis Belini-Junior3
1Universidade Federal de Pernambuco (UFPE), Recife, SP, Brazil; Universidade de São Paulo (USP), Ribeirão Preto, SP, Brazil.
Introduction:
Sickle cell anemia (SCA) is a Mendelian disorder with a heterogeneous clinical course. The reasons for this phenotypic diversity are not entirely established, but it is known that high fetal hemoglobin levels lead to a milder course of the disease. Additionally, genetic variants in the intergenic region HBS1L-MYB promote high levels of fetal hemoglobin into adulthood.
Objective:
In the present study, we investigated the HMIP1 C-839A (rs9376092) polymorphism, located at the HBS1L-MYB intergenic region block 1, in SCA patients.
Method:
We analyzed 299 SCA patients followed in two reference centers in Brazil. The HMIP1 C-839A (rs9376092) genotypes were determined by allele specific polymerase chain reactions. Clinical and laboratory data were obtained from patient interviews and medical records.
Results:
The median fetal hemoglobin levels were higher in patients with the HMIP1 C-839A (rs9376092) AA genotype (CC=6.4%, CA=5.6% and AA=8.6%), but this difference did not reach significance (p=0.194). No association between HMIP1 C-839A (rs9376092) genotypes and other clinical and laboratorial features was detected (p>0.05).
Conclusion:
In summary, our data could not support the previously related association between the HMIP1 C-893A (rs9376092) polymorphism and differential fetal hemoglobin levels.
Insights
This study found no significant association between the HMIP1 C-839A polymorphism and fetal hemoglobin levels in sickle cell anemia patients. Further research is needed to understand the genetic factors influencing sickle cell anemia
Area of Science:
- Genetics
- Hematology
- Molecular Biology
Background:
- Sickle cell anemia (SCA) exhibits variable clinical severity, influenced by fetal hemoglobin (HbF) levels.
- Genetic variants in the HBS1L-MYB intergenic region are known to affect adult HbF levels.
Purpose of the Study:
- To investigate the association of the HMIP1 C-839A (rs9376092) polymorphism with HbF levels and clinical features in SCA patients.
- To explore the role of this specific genetic variant in the phenotypic diversity of SCA.
Main Methods:
- Genotyping of the HMIP1 C-839A (rs9376092) polymorphism using allele-specific PCR.
- Analysis of 299 SCA patients from two Brazilian reference centers.
- Collection of clinical and laboratory data through interviews and medical records.
Main Results:
- Median HbF levels were slightly higher in patients with the AA genotype (8.6%) compared to CC (6.4%) and CA (5.6%), but this difference was not statistically significant (p=0.194).
- No significant associations were found between the HMIP1 C-839A genotypes and other clinical or laboratory features of SCA (p>0.05).
Conclusions:
- The study did not find evidence to support a link between the HMIP1 C-893A (rs9376092) polymorphism and varying fetal hemoglobin levels in sickle cell anemia.
- The genetic factors contributing to the diverse clinical presentation of SCA remain incompletely understood.
More Related Videos
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
08:23Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
Related Concept Videos
Multiple Allele Traits
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Genetic Lingo
Single Nucleotide Polymorphisms-SNPs
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...